<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is a hematopoietic stem-cell disorder characterized by trilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and susceptibility to <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Analysis of molecular basis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> has been hampered by the <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of the disease </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, mutations of the transcription factor AML1/RUNX1 have been identified in 15% to 40% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We performed mouse bone marrow transplantation (BMT) using bone marrow cells transduced with the AML1 mutants </plain></SENT>
<SENT sid="4" pm="."><plain>Most mice developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-like symptoms within 4 to 13 months after BMT </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, among integration sites identified, Evi1 seemed to collaborate with an AML1 mutant harboring a point mutation in the <z:mp ids='MP_0001265'>Runt</z:mp> homology domain (D171N) to induce <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with an identical phenotype characterized by marked <z:hpo ids='HP_0001433'>hepatosplenomegaly</z:hpo>, myeloid <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, <z:hpo ids='HP_0001974'>leukocytosis</z:hpo>, and biphenotypic surface markers </plain></SENT>
<SENT sid="6" pm="."><plain>Collaboration between AML1-D171N and Evi1 was confirmed by a BMT model where coexpression of AML1-D171N and Evi1 induced <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> of the same phenotype with much shorter latencies </plain></SENT>
<SENT sid="7" pm="."><plain>On the other hand, a C-terminal truncated AML1 mutant (S291fsX300) induced <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> with erythroid <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in transplanted mice, followed by progression to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, we have developed a useful mouse model of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> that should help in the understanding of the molecular basis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and the progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to overt <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>